IBDEI3GQ ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,58245,2)
 ;;=^5005286
 ;;^UTILITY(U,$J,358.3,58246,0)
 ;;=H54.0^^272^2904^1
 ;;^UTILITY(U,$J,358.3,58246,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,58246,1,3,0)
 ;;=3^Blindness,Both Eyes
 ;;^UTILITY(U,$J,358.3,58246,1,4,0)
 ;;=4^H54.0
 ;;^UTILITY(U,$J,358.3,58246,2)
 ;;=^5006357
 ;;^UTILITY(U,$J,358.3,58247,0)
 ;;=H54.12^^272^2904^2
 ;;^UTILITY(U,$J,358.3,58247,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,58247,1,3,0)
 ;;=3^Blindness-Left Eye/Low Vision-Right Eye
 ;;^UTILITY(U,$J,358.3,58247,1,4,0)
 ;;=4^H54.12
 ;;^UTILITY(U,$J,358.3,58247,2)
 ;;=^5006360
 ;;^UTILITY(U,$J,358.3,58248,0)
 ;;=H54.11^^272^2904^4
 ;;^UTILITY(U,$J,358.3,58248,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,58248,1,3,0)
 ;;=3^Blindness-Right Eye/Low Vision-Left Eye
 ;;^UTILITY(U,$J,358.3,58248,1,4,0)
 ;;=4^H54.11
 ;;^UTILITY(U,$J,358.3,58248,2)
 ;;=^5006359
 ;;^UTILITY(U,$J,358.3,58249,0)
 ;;=H54.2^^272^2904^7
 ;;^UTILITY(U,$J,358.3,58249,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,58249,1,3,0)
 ;;=3^Low Vision,Both Eyes
 ;;^UTILITY(U,$J,358.3,58249,1,4,0)
 ;;=4^H54.2
 ;;^UTILITY(U,$J,358.3,58249,2)
 ;;=^5006361
 ;;^UTILITY(U,$J,358.3,58250,0)
 ;;=H54.3^^272^2904^8
 ;;^UTILITY(U,$J,358.3,58250,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,58250,1,3,0)
 ;;=3^Unqualified Visual Loss,Both Eyes
 ;;^UTILITY(U,$J,358.3,58250,1,4,0)
 ;;=4^H54.3
 ;;^UTILITY(U,$J,358.3,58250,2)
 ;;=^268886
 ;;^UTILITY(U,$J,358.3,58251,0)
 ;;=H54.41^^272^2904^5
 ;;^UTILITY(U,$J,358.3,58251,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,58251,1,3,0)
 ;;=3^Blindness-Right Eye/Normal Vision-Left Eye
 ;;^UTILITY(U,$J,358.3,58251,1,4,0)
 ;;=4^H54.41
 ;;^UTILITY(U,$J,358.3,58251,2)
 ;;=^5006363
 ;;^UTILITY(U,$J,358.3,58252,0)
 ;;=H54.42^^272^2904^3
 ;;^UTILITY(U,$J,358.3,58252,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,58252,1,3,0)
 ;;=3^Blindness-Left Eye/Normal Vision-Right Eye
 ;;^UTILITY(U,$J,358.3,58252,1,4,0)
 ;;=4^H54.42
 ;;^UTILITY(U,$J,358.3,58252,2)
 ;;=^5133518
 ;;^UTILITY(U,$J,358.3,58253,0)
 ;;=H54.7^^272^2904^9
 ;;^UTILITY(U,$J,358.3,58253,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,58253,1,3,0)
 ;;=3^Visual Loss,Unspec
 ;;^UTILITY(U,$J,358.3,58253,1,4,0)
 ;;=4^H54.7
 ;;^UTILITY(U,$J,358.3,58253,2)
 ;;=^5006368
 ;;^UTILITY(U,$J,358.3,58254,0)
 ;;=H54.8^^272^2904^6
 ;;^UTILITY(U,$J,358.3,58254,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,58254,1,3,0)
 ;;=3^Legal Blindness,as Defined in USA
 ;;^UTILITY(U,$J,358.3,58254,1,4,0)
 ;;=4^H54.8
 ;;^UTILITY(U,$J,358.3,58254,2)
 ;;=^5006369
 ;;^UTILITY(U,$J,358.3,58255,0)
 ;;=E11.9^^272^2905^26
 ;;^UTILITY(U,$J,358.3,58255,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,58255,1,3,0)
 ;;=3^DM Type 2 w/o Complications
 ;;^UTILITY(U,$J,358.3,58255,1,4,0)
 ;;=4^E11.9
 ;;^UTILITY(U,$J,358.3,58255,2)
 ;;=^5002666
 ;;^UTILITY(U,$J,358.3,58256,0)
 ;;=E11.39^^272^2905^15
 ;;^UTILITY(U,$J,358.3,58256,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,58256,1,3,0)
 ;;=3^DM Type 2 w/ Diabetic Ophthalmic Complications
 ;;^UTILITY(U,$J,358.3,58256,1,4,0)
 ;;=4^E11.39
 ;;^UTILITY(U,$J,358.3,58256,2)
 ;;=^5002643
 ;;^UTILITY(U,$J,358.3,58257,0)
 ;;=E11.36^^272^2905^14
 ;;^UTILITY(U,$J,358.3,58257,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,58257,1,3,0)
 ;;=3^DM Type 2 w/ Diabetic Cataract
 ;;^UTILITY(U,$J,358.3,58257,1,4,0)
 ;;=4^E11.36
 ;;^UTILITY(U,$J,358.3,58257,2)
 ;;=^5002642
 ;;^UTILITY(U,$J,358.3,58258,0)
 ;;=E11.359^^272^2905^20
 ;;^UTILITY(U,$J,358.3,58258,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,58258,1,3,0)
 ;;=3^DM Type 2 w/ Prolif Diab Retinopathy w/o Macular Edema
 ;;^UTILITY(U,$J,358.3,58258,1,4,0)
 ;;=4^E11.359
